Metlife, Inc. (MET - Free Report) just released its fourth quarter fiscal 2016 earnings results, posting earnings of $1.28 per share and revenue of $17.2 billion.
MET was down 1.05% to $53.75 in after-hours trading shortly after its earnings report was released.
Currently, MET has a Zacks Rank #4 (Sell), but it is subject to change following the release of the company’s latest earnings report. Here are 5 key statistics from this just announced report below.
Metlife:
Missed earnings estimates. The company posted earnings of $1.28 cents per share, missing our Zacks Consensus Estimate of $1.34 a share.
Missed revenue estimates. The company saw revenue figures of $17.2 billion, missed our estimate of $17.303 billion.
Metlife reported a net loss of $2.1 billion according to a GAAP basis. The net loss includes $3.2 billion after tax net derivative losses.
For the full year of 2016, Metlife’s earnings were $5.1 billion which is 7% down from the previous year.
“For full-year 2016 excluding notable items, market factors and underwriting reduced earnings while management actions to control expenses and generate volume growth were positive” said Metlife chairman, president and CEO Steven Kandarian.
Here’s a graph that looks at Metlife’s price, consensus and EPS surprise:
Metlife Inc. provides insurance, annuities, employee benefits, and property & casualty insurance. Along with other financial services, Metlife runs their operations in the United States, Europe, Japan, Latin America, and Middle East. The New York headquartered company employs 66,000 individuals and went public in 2000. Metlife was founded 1868 and is one of the largest global providers of insurance.
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?
Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Metlife, Inc. (MET - Free Report) just released its fourth quarter fiscal 2016 earnings results, posting earnings of $1.28 per share and revenue of $17.2 billion.
MET was down 1.05% to $53.75 in after-hours trading shortly after its earnings report was released.
Currently, MET has a Zacks Rank #4 (Sell), but it is subject to change following the release of the company’s latest earnings report. Here are 5 key statistics from this just announced report below.
Metlife:
Missed earnings estimates. The company posted earnings of $1.28 cents per share, missing our Zacks Consensus Estimate of $1.34 a share.
Missed revenue estimates. The company saw revenue figures of $17.2 billion, missed our estimate of $17.303 billion.
Metlife reported a net loss of $2.1 billion according to a GAAP basis. The net loss includes $3.2 billion after tax net derivative losses.
For the full year of 2016, Metlife’s earnings were $5.1 billion which is 7% down from the previous year.
“For full-year 2016 excluding notable items, market factors and underwriting reduced earnings while management actions to control expenses and generate volume growth were positive” said Metlife chairman, president and CEO Steven Kandarian.
Here’s a graph that looks at Metlife’s price, consensus and EPS surprise:
Metlife Inc. provides insurance, annuities, employee benefits, and property & casualty insurance. Along with other financial services, Metlife runs their operations in the United States, Europe, Japan, Latin America, and Middle East. The New York headquartered company employs 66,000 individuals and went public in 2000. Metlife was founded 1868 and is one of the largest global providers of insurance.
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?
Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MET - FREE